Provided by Tiger Trade Technology Pte. Ltd.

Absci Corporation.

8.71
-0.7100-7.54%
Pre-market: 8.800.0900+1.03%06:38 EDT
Volume:2.51M
Turnover:22.13M
Market Cap:1.49B
PE:-10.89
High:9.30
Open:9.20
Low:8.60
Close:9.42
52wk High:12.06
52wk Low:2.24
Shares:171.61M
Float Shares:156.49M
Volume Ratio:0.98
T/O Rate:1.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7999
EPS(LYR):-0.8421
ROE:-57.72%
ROA:-34.10%
PB:6.07
PE(LYR):-10.34

Loading ...

Absci Corp expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
May 06

Absci grants 276,200-share stock option at $4.92 under inducement plan

Reuters
·
May 05

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 05

BUZZ-Absci rises as brokerage highlights growing opportunity in hair‑loss market

Reuters
·
Apr 28

Analysts Offer Insights on Healthcare Companies: AbSci (ABSI) and RenovoRx (RNXT)

TIPRANKS
·
Apr 01

Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX), AbSci (ABSI) and MaxCyte (MXCT)

TIPRANKS
·
Mar 30

Absci Price Target Maintained With a $7.00/Share by Needham

Dow Jones
·
Mar 30

Absci Shares Fall 4.9% After Q4 Results

THOMSON REUTERS
·
Mar 25

Absci, DigitalOcean And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Benzinga
·
Mar 25

Absci price target lowered to $4.20 from $4.32 at Morgan Stanley

TIPRANKS
·
Mar 25

Absci Price Target Maintained With a $7.00/Share by Needham

Dow Jones
·
Mar 25

AbSci (ABSI) Gets a Buy from Guggenheim

TIPRANKS
·
Mar 25

Absci Corp : Morgan Stanley Cuts Target Price to $4.20 From $4.32

THOMSON REUTERS
·
Mar 25

Analysts Conflicted on These Healthcare Names: Fractyl Health, Inc. (GUTS), AbSci (ABSI) and Alnylam Pharma (ALNY)

TIPRANKS
·
Mar 25

Absci Shares Fall on Wider 4Q Loss, Lower Revenue

Dow Jones
·
Mar 25

Absci Shares Fall 9% Premarket After Q4 Results

THOMSON REUTERS
·
Mar 25

U.S. RESEARCH ROUNDUP-Amazon, Diamondback Energy, Matador Resources

Reuters
·
Mar 25

Absci Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 25

BRIEF-Absci Corp Q4 Revenue Was $0.7 Million

Reuters
·
Mar 25

Absci Q4 EPS $(0.20), Inline, Sales $650.000K Miss $1.100M Estimate

Benzinga Earnings
·
Mar 25